Innate Pharma is a French biotechnology company that discovers, develops and markets therapeutic antibodies for treating oncology indications worldwide, including cutaneous and peripheral T-cell lymphoma. The company has a portfolio of six products currently in clinical trials, including immune checkpoint inhibitors and monoclonal antibodies for COVID-19 and other inflammatory diseases. Innate Pharma has collaboration and license agreements with several reputable companies, including AstraZeneca and Sanofi, and is based in Marseille, France.